• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口服两亲性肽作为治疗剂。

Oral amphipathic peptides as therapeutic agents.

作者信息

Reddy Srinivasa T, Anantharamaiah G M, Navab Mohamad, Hama Susan, Hough Gregory, Grijalva Victor, Garber David W, Datta Geeta, Fogelman Alan M

机构信息

Division of Cardiology, Department of Medicine, David Geffen School of Medicine, UCLA, Los Angeles, California 90095-1679, USA.

出版信息

Expert Opin Investig Drugs. 2006 Jan;15(1):13-21. doi: 10.1517/13543784.15.1.13.

DOI:10.1517/13543784.15.1.13
PMID:16370930
Abstract

Cholesterol can promote inflammation by its ability to stimulate the production of reactive oxygen species that result in the formation of pro-inflammatory oxidised phospholipids. High-density lipoproteins (HDLs) are part of the innate immune response and can be either pro- or anti-inflammatory independently of plasma HDL-cholesterol levels. During systemic inflammation as occurs with atherosclerosis, Apolipoprotein A-I can be altered, reducing its ability to promote reverse cholesterol transport and HDL can become pro-inflammatory. Amphipathic peptides with either a class A amphipathic helix (D-4F) or a class G* amphipathic helix (D-[113-122]apoJ), or even those that are too small to form a helix (KRES and FREL) have some similar characteristics. Their interaction with lipids leads to a reduction in lipoprotein-lipid hydroperoxides that releases HDL-associated antioxidant enzymes, such as paraoxonase, therefore providing antiatherosclerosis and anti-inflammatory activity. In addition, the peptide D-4F stimulates the formation and cycling of pre-beta HDL. These amphipathic peptides appear to have therapeutic potential as oral agents.

摘要

胆固醇能够通过刺激活性氧的产生来促进炎症,活性氧会导致促炎性氧化磷脂的形成。高密度脂蛋白(HDL)是先天性免疫反应的一部分,并且可以独立于血浆HDL-胆固醇水平而具有促炎或抗炎作用。在诸如动脉粥样硬化时发生的全身炎症期间,载脂蛋白A-I可能会发生改变,降低其促进胆固醇逆向转运的能力,并且HDL可能会变得具有促炎性。具有A类两亲性螺旋(D-4F)或G*类两亲性螺旋(D-[113-122]载脂蛋白J)的两亲性肽,甚至那些太小而无法形成螺旋的肽(KRES和FREL)都具有一些相似的特性。它们与脂质的相互作用会导致脂蛋白-脂质氢过氧化物减少,从而释放出与HDL相关的抗氧化酶,如对氧磷酶,因此具有抗动脉粥样硬化和抗炎活性。此外,肽D-4F会刺激前β-HDL的形成和循环。这些两亲性肽似乎具有作为口服药物的治疗潜力。

相似文献

1
Oral amphipathic peptides as therapeutic agents.口服两亲性肽作为治疗剂。
Expert Opin Investig Drugs. 2006 Jan;15(1):13-21. doi: 10.1517/13543784.15.1.13.
2
An oral apoJ peptide renders HDL antiinflammatory in mice and monkeys and dramatically reduces atherosclerosis in apolipoprotein E-null mice.口服载脂蛋白J肽可使小鼠和猴子体内的高密度脂蛋白具有抗炎作用,并显著减轻载脂蛋白E基因敲除小鼠的动脉粥样硬化。
Arterioscler Thromb Vasc Biol. 2005 Sep;25(9):1932-7. doi: 10.1161/01.ATV.0000174589.70190.e2. Epub 2005 Jun 16.
3
Apolipoprotein A-I mimetic peptides.载脂蛋白A-I模拟肽
Arterioscler Thromb Vasc Biol. 2005 Jul;25(7):1325-31. doi: 10.1161/01.ATV.0000165694.39518.95. Epub 2005 Apr 14.
4
HDL apolipoprotein-related peptides in the treatment of atherosclerosis and other inflammatory disorders.高密度脂蛋白载脂蛋白相关肽在动脉粥样硬化和其他炎症性疾病中的治疗作用。
Curr Pharm Des. 2010;16(28):3173-84. doi: 10.2174/138161210793292492.
5
Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice.口服D-4F可导致前β高密度脂蛋白的形成,并改善载脂蛋白E基因敲除小鼠中高密度脂蛋白介导的胆固醇流出以及巨噬细胞的胆固醇逆向转运。
Circulation. 2004 Jun 29;109(25):3215-20. doi: 10.1161/01.CIR.0000134275.90823.87. Epub 2004 Jun 14.
6
Apolipoprotein A-I mimetic peptides: a potential new therapy for the prevention of atherosclerosis.载脂蛋白 A-I 模拟肽:预防动脉粥样硬化的潜在新疗法。
Cardiol Rev. 2010 May-Jun;18(3):141-7. doi: 10.1097/CRD.0b013e3181c4b508.
7
The dual nature of HDL: Anti-Inflammatory and pro-Inflammatory.高密度脂蛋白的双重性质:抗炎和促炎。
Biofactors. 2015 May 6;41(3):153-9. doi: 10.1002/biof.1205. Epub 2015 Jun 13.
8
Human apolipoprotein A-I and A-I mimetic peptides: potential for atherosclerosis reversal.人载脂蛋白A-I与A-I模拟肽:逆转动脉粥样硬化的潜力。
Curr Opin Lipidol. 2004 Dec;15(6):645-9. doi: 10.1097/00041433-200412000-00004.
9
Oral small peptides render HDL antiinflammatory in mice and monkeys and reduce atherosclerosis in ApoE null mice.
Circ Res. 2005 Sep 16;97(6):524-32. doi: 10.1161/01.RES.0000181229.69508.2f. Epub 2005 Aug 11.
10
Subcutaneous Administration of Apolipoprotein J-Derived Mimetic Peptide d-[113-122]apoJ Improves LDL and HDL Function and Prevents Atherosclerosis in LDLR-KO Mice.皮下给予载脂蛋白 J 衍生模拟肽 d-[113-122]apoJ 可改善 LDL 和 HDL 功能并预防 LDLR-KO 小鼠的动脉粥样硬化。
Biomolecules. 2020 May 29;10(6):829. doi: 10.3390/biom10060829.

引用本文的文献

1
Recombinant Human Clusterin Seals Damage to the Ocular Surface Barrier in a Mouse Model of Ophthalmic Preservative-Induced Epitheliopathy.重组人聚集素可封闭眼科防腐剂诱导的眼表上皮病模型中眼表屏障的损伤。
Int J Mol Sci. 2023 Jan 4;24(2):981. doi: 10.3390/ijms24020981.
2
Therapeutic Potential of the Molecular Chaperone and Matrix Metalloproteinase Inhibitor Clusterin for Dry Eye.分子伴侣和基质金属蛋白酶抑制剂簇蛋白治疗干眼症的潜力。
Int J Mol Sci. 2020 Dec 24;22(1):116. doi: 10.3390/ijms22010116.
3
Making sense of a seemingly odd connection.
理解一种看似奇怪的联系。
Eur Heart J. 2017 Dec 21;38(48):3588-3589. doi: 10.1093/eurheartj/ehx506.
4
A Novel Anti-Inflammatory Effect for High Density Lipoprotein.高密度脂蛋白的一种新型抗炎作用。
PLoS One. 2015 Dec 17;10(12):e0144372. doi: 10.1371/journal.pone.0144372. eCollection 2015.
5
Overexpression of apolipoprotein A1 in the lung abrogates fibrosis in experimental silicosis.肺内载脂蛋白 A1 的过表达可消除实验性矽肺中的纤维化。
PLoS One. 2013;8(2):e55827. doi: 10.1371/journal.pone.0055827. Epub 2013 Feb 8.
6
HDL mimetics inhibit tumor development in both induced and spontaneous mouse models of colon cancer.高密度脂蛋白模拟物可抑制结肠癌诱导和自发小鼠模型中的肿瘤发展。
Mol Cancer Ther. 2012 Jun;11(6):1311-9. doi: 10.1158/1535-7163.MCT-11-0905. Epub 2012 Mar 13.
7
Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer.载脂蛋白 A-I(apoA-I)和载脂蛋白 A-I 模拟肽可抑制卵巢癌小鼠模型中的肿瘤发展。
Proc Natl Acad Sci U S A. 2010 Nov 16;107(46):19997-20002. doi: 10.1073/pnas.1009010107. Epub 2010 Nov 1.
8
Vasculoprotective Effects of Apolipoprotein Mimetic Peptides: An Evolving Paradigm In Hdl Therapy (Vascular Disease Prevention, In Press.).载脂蛋白模拟肽的血管保护作用:HDL治疗中不断发展的范例(《血管疾病预防》,即将出版)。
Vasc Dis Prev. 2009 Jan 1;6:122-130. doi: 10.2174/1567270000906010122.
9
HDL therapy for cardiovascular diseases: the road to HDL mimetics.用于心血管疾病的高密度脂蛋白疗法:通向高密度脂蛋白模拟物之路。
Curr Atheroscler Rep. 2008 Oct;10(5):405-12. doi: 10.1007/s11883-008-0063-6.
10
Peptide Mimetics of Apolipoproteins Improve HDL Function.载脂蛋白肽类似物改善高密度脂蛋白功能。
J Clin Lipidol. 2007 May;1(2):142-7. doi: 10.1016/j.jacl.2007.03.002.